Saaya Tsutsué^1*, Takahiro Suzuki², Hyojin Kim^3*, William YuanHao Kuan^3* and Bruce Crawford^3*

¹HEOR, Celgene K.K., a Bristol-Myers Squibb Company, Tokyo, Japan
²Division of Hematology, Department of Medicine, Kitasato University School of Medicine, Kanagawa, Japan
³Syneos Health, Tokyo, Japan

Gabriela Sanchez-Petitto, MD¹, Olga Goloubeva, PhD, MSc^2*, James Childress, MD^3*, Tahreem Iqbal, MD^3*, Jack Masur, MD^3*, Max An, BS^4*, Safwan Muhammad, MD^3*, Justin Lawson, PharmD BCOP^1*, Jasmin Sahbaz, MD^5*, Brian Barr, MD^4,5*, Vu H. Duong, MD^1,4, Jennie Y. Law, MD^1,4,6, Ashkan Emadi, M.D., Ph.D.^1,7, Maria R. Baer, M.D.^2,6,8 and Sandrine Niyongere, MD^1,4

¹Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
³Department of Internal Medicine, University of Maryland, Baltimore
⁴University of Maryland School of Medicine, Baltimore, MD
⁵Division of Cardiology, University of Maryland, Baltimore, MD
⁶Veterans Affairs Medical Center, Baltimore, MD
⁷Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
⁸Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD

Tommi Tervonen^1,2*, Katelyn Cutts^3*, Jaein Seo^3*, Salem Abi Nehme^4*, Ignazia La Torre^4*, Thibaud Prawitz^1*, Clara Chen^4*, CL Beach^4* and Jenny Wang^4*

¹Evidera, London, United Kingdom
²University Medical Center Groningen, Groningen, Netherlands
³Evidera, Bethesda, MD
⁴Bristol Myers Squibb, Princeton, NJ

Larysa Sanchez, MD^1*, Xavier Leleu, MD², Jennifer Beaumont^3*, Hailin Yu^3*, Stacie Hudgens, MA^3*, Holger W Auner, MD, PhD⁴, Hang Quach, MD⁵, Sosana Delimpasi, MD^6*, Ivan Spicka, MD, PhD^7*, Luděk Pour, MD^8*, Meletios A Dimopoulos⁹, Halyna Pylypenko, MD^10*, Vadim A Doronin, MD^11*, Ganna Usenko, MD^12*, Roman Hajek, MD, PhD¹³, Reuben Benjamin, MD¹⁴, Christopher P. Venner, MD¹⁵, Mamta Garg, MD, FRCP, FRCPath^16*, Don A. Stevens, MD¹⁷, Sundar Jagannath, MD^18*, Philippe Moreau^19*, Moshe Levy, MD^20*, Nizar Bahlis, MD²¹, Thierry Facon, MD^22*, Yi Chai^23*, Xiwen Ma^23*, Shijie Tang^23*, Hoyee Leong^23*, Jatin J. Shah, MD^23*, Sharon Shacham, PhD, MBA^23*, Michael G Kauffman, MD, PhD²³, Paul G. Richardson, MD²⁴ and Sebastian Grosicki, MD, PhD²⁵

¹Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York
²CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, POITIERS, France
³Clinical Outcomes Solutions, Tucson, AZ
⁴Imperial College Healthcare NHS Trust, London, United Kingdom
⁵St. Vincent’s Hospital, Fitzroy, VIC, Australia
⁶Hematology/Lymphomas and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁷1st Internal Clinic - Clinic of Hematology, General University Hospital, Prague, Czech Republic
⁸Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
⁹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
¹⁰Regional Treatment and Diagnostic Hematology Center, Cherkassy Regional Oncology Dispensary of Cherkasy Regional Council, Cherkassy, Ukraine
¹¹Hematology Department, State Budget Healthcare Institution of Moscow, City Clinical Hospital #40 of Moscow Healthcare Department, Moscow, Russian Federation
¹²City Clinical Hospital No. 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine
¹³Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
¹⁴Kings College Hospital NHS Foundation Trust, London, United Kingdom
¹⁵Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
¹⁶University Hospitals Leicester NHS Trust, Leicester, United Kingdom
¹⁷Norton Cancer Institute - St Matthews Campus, Louisville, KY
¹⁸Icahn School of Medicine at Mount Sinai, New York, NY
¹⁹CHU Hotel-Dieu, Nantes, France
²⁰Baylor University Medical Center, Dallas, TX
²¹University of Calgary, Charbonneau Cancer Institute, Calgary, AB, Canada
²²CHU Lille, Service des Maladies du Sang F-59000, Lille, France
²³Karyopharm Therapeutics, Newton, MA
²⁴Dana-Farber Cancer Institute, Boston, MA
²⁵Clinical Department of Hematology and Prophylaxis of Cancer Diseases, Independent Public Healthcare Facility Municipal Hospital Group, Chórzow, Poland

Jodi J Lipof, MD¹, Dharmini Manogna, MD², Andrea M. Baran, MS^3*, Bassil Said, MD^4*, Michael W. Becker, MD¹, Jason H. Mendler, MD, PhD¹, Omar S. Aljitawi, MD¹, Kristen Marie O'Dwyer, MD⁵, Eric Huselton, MD⁶, Richard Burack, MD, PhD⁷, Margaret Blaney^1*, Taylor Douglas^1*, Jane L. Liesveld, MD³ and Melissa Loh, MBBCHBAO¹

¹Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
²Division of Internal Medicine, Rochester General Hospital, Rochester, NY
³Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁴Internal Medicine, Rochester General Hospital, Rochester, NY
⁵University of Rochester Medical Center, Rochester, NY
⁶Division of Hematology and Oncology, University of Rochester Medical Center, Rochester, NY
⁷Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY

Melissa Loh, MBBCHBAO¹, Mazie Tsang, MD², Thomas W. Leblanc³, Anthony Back, MD^4*, Paul Duberstein, PhD^5*, Supriya G. Mohile, MD, MS^1*, Ronald Epstein, MD^6*, Heidi D. Klepin, MD⁷, Michael W. Becker, MD¹, Areej El-Jawahri, MD⁸ and Stephanie J. Lee, MD, MPH⁹

¹Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
²Hematology/Oncology, UCSF, San Francisco, CA
³Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
⁴University of Washington, Seattle, WA
⁵Department of Psychiatry, University of Rochester Medical Center, Rochester, NY
⁶University of Rochester Medical Center, ROCHESTER, NY
⁷Wake Forest University School of Medicine, Winston Salem, NC
⁸Massachusetts General Hospital / Harvard Medical School, Allston, MA
⁹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Shaloo Gupta^1*, Thomas Schroeder^2*, Austin G Kulasekararaj, MD, MBBS, MRCP, FRCPath³, Halley Costantino^1*, Jay Grisolano^1*, Jackson Tang^4*, Shalon Jones^4* and Derek Tang^4*

¹Kantar, New York, NY
²Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany
³King's College Hospital - NHS Foundation Trust, NIHR Wellcome King’s Clinical Research Facility, London and King’s College London, London, United Kingdom
⁴Bristol Myers Squibb, Princeton, NJ

Hermioni L. Amonoo, MD^1,2,3*, Areej El-Jawahri, MD^2,4, Thomas W. LeBlanc, MD, MA, MS⁵, Alison R. Kavanaugh, NP^2,6*, Jason A. Webb, MD^5*, Lara Traeger, Ph.D.^2,6*, Annemarie D. Jagielo, BA^6*, Dagny M. Vaughn, MS^6*, Madeleine Elyze, BA^6*, Regina M. Longley, BA^6*, Amir T. Fathi^2,6, Gabriela S. Hobbs, MD^2,6, Andrew M. Brunner^2,6*, Nina R. O’Connor, MD^7*, Selina M. Luger, MD, FRCPC⁸, Jillian Gustin, MD^9*, Bhavana Bhatnagar, DO¹⁰ and Nora K. Horick, MS^2,6*

¹Dana-Farber Cancer Institute, Boston, MA
²Harvard Medical School, Boston, MA
³Brigham and Women's Hospital, Boston, MA
⁴Massachusetts General Hospital / Harvard Medical School, Allston, MA
⁵Duke University School of Medicine, Durham, NC
⁶Massachusetts General Hospital, Boston, MA
⁷University of Pennsylvania, Philadelphia, PA
⁸Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁹Palliative Medicine, The Ohio State University, Columbus, OH
¹⁰Hematology, The Ohio State University, Columbus, OH